肝硬化患者多期增强MRI上LI-RADS®观察不一致的患病率及临床意义
这项横断面研究纳入93例肝硬化患者,评估多期增强MRI上两位腹部放射科医师独立判读LI-RADS®观察的一致性。可报告和可操作观察的总体一致率分别仅为32.3%和40.1%;不一致的LI-RADS®观察在30例(43.5%)中可能影响临床管理,其中多数(66.7%)源于检出不一致。
要点
- 可报告观察(LR-3/4/5/M)两位医师总体一致率仅32.3%,可操作观察(LR-4/5/M)仅40.1%。
- 总体一致率低主要源于检出一致率低(可报告52.0%、可操作62.5%)及LI-RADS®分类一致率不理想。
- 不一致的LI-RADS®观察在30例(43.5%)中可能影响随访影像、活检转诊、肝移植资格或治疗方式。
核心结论
- 肝硬化患者多期增强MRI的LI-RADS®观察不一致较常见,可能对患者管理有潜在影响。
研究设计与样本
- 横断面研究纳入93例因评估肝细胞癌行1.5或3 T多期增强MRI的肝硬化患者。
- 两位腹部放射科医师独立判读T1、T2、扩散加权平扫图像及多期增强T1加权脂肪抑制图像,并按LI-RADS®报告肝脏观察。
- 记录检出(是否两位医师共同检出)、大小分类(<10;10–19;≥20 mm)及LI-RADS®分类(可报告LR-3/4/5/M、可操作LR-4/5/M)的一致性。
- 总体一致性(检出、大小及LI-RADS®分类均一致)计算95%置信区间,并分别计算检出、大小及LI-RADS®分类的一致性。
- 不一致的临床意义评估为对随访影像、活检转诊、肝移植资格或治疗方式的影响。
诊断标准与关键数值
- 可报告观察(LR-3/4/5/M)总体一致率32.3%[24.6, 41.0]。
- 可操作观察(LR-4/5/M)总体一致率40.1%[29.5, 51.5]。
- 可报告观察检出一致率52.0%[44.3, 59.5],LI-RADS®分类一致率73.7%[61.6, 83.1]。
- 可操作观察检出一致率62.5%[52.3, 71.8],LI-RADS®分类一致率70.9%[57.3, 81.6]。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the prevalence and clinical significance of discordant LI-RADS® (Liver Imaging Reporting and Data System) liver observations on multiphase contrast-enhanced (MCE) magnetic resonance imaging (MRI) in patients with cirrhosis.
METHODS: This cross-sectional study included 93 cirrhosis patients who underwent 1.5 or 3 T MCE MRI for evaluation of hepatocellular carcinoma (HCC). Two abdominal radiologists independently reviewed T1-, T2-, diffusion-weighted unenhanced images as well as MCE T1-weighted fat-suppressed images and reported liver observations using LI-RADS®. Concordance were recorded for detection (co-detected by both radiologists or not), size category (< 10; 10-19; ≥ 20 mm), and LI-RADS® category assignment as reportable (LR-3/4/5/M) and actionable (LR-4/5/M). The overall concordance (i.e., concordant in detection, size, and LR-category) was calculated with 95% confidence interval [CI], and separately for detection, size, and LR-category. Clinical significance of discordance was assessed as impact on follow-up imaging, referral for biopsy, liver transplant eligibility, or treatment modality.
RESULTS: Reportable and actionable observations were overall concordant between two radiologists only in 32.3% [24.6, 41.0] and 40.1% [29.5, 51.5] of cases, respectively. Poor overall concordance was related to detection concordance of 52.0% [44.3, 59.5] and 62.5% [52.3, 71.8], as well as LR-category concordance of 73.7% [61.6, 83.1] and 70.9% [57.3, 81.6], for reportable and actionable observations, respectively. Discordant LI-RADS® observations would have impacted clinical management in 30 subjects (43.5%), most (66.7%) of whom were due to discordant detection.
CONCLUSION: Discordant MRI LI-RADS® observations are common in patients with cirrhosis and may have potential implications for patient management.
引用
- Yokoo T, Singal AG, Diaz de Leon A, et al. Prevalence and clinical significance of discordant LI-RADS® observations on multiphase contrast-enhanced MRI in patients with cirrhosis. Abdom Radiol (NY). 2020. PMID: 31342103. doi:10.1007/s00261-019-02133-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。